TEPROTUMUMAB

UNII:	Y64GQ0KC0A
Formula:
Preferred Substance Name:	TEPROTUMUMAB

1036734-93-6
289-554-4
HZN001
HZN-001
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (CD221)), HUMAN MONOCLONAL IMC-11F8 .GAMMA.1 HEAVY CHAIN (221-215')-DISULFIDE WITH HUMAN MONOCLONAL IMC-11F8 .KAPPA. LIGHT, DIMER (227-227'':230-230'')-BISDISULFIDE
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
R-1507
RG1507
RG-1507
RO4858696
RO-4858696
RO4858696-000
RO-4858696000
RO-4858696-000
RV001 MONOCLONAL
RV-001 MONOCLONAL
TEPEZZA
TEPROTUMUMAB [INN]
TEPROTUMUMAB [MI]
TEPROTUMUMAB [USAN]
TEPROTUMUMAB [WHO-DD]
TEPROTUMUMAB TRBW [WHO-DD]
TEPROTUMUMAB-TRBW

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TEPROTUMUMAB

Synonyms and Mappings

Resources